Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.


The eOGTTK study evaluated the feasibility of using a disposable, self-administered, capillary blood sampling electronic oral glucose tolerance test kit in a community setting. The accuracy and repeatability of the glucose measurements were assessed, as well as whether participants were able to use the kit unaided, and their feelings about self-assessment.


Randomised, crossover, parallel group study in healthy volunteers and people with type 2 diabetes.


The study showed that self-administered eOGTTs using this kit could be conducted successfully by untrained individuals in a community setting. With improved device reliability and appropriate calibration, this novel technology could be used in routine practice to diagnose impaired glucose tolerance or diabetes. The published results are available here.

Chief investigator

Rury Holman


Novartis Pharma AG


Novartis Pharma AG

Reference number



New DTU study finds that screening for diabetes could be done at home

Research published online today led by DTU researchers has found that people may be able to test themselves for diabetes in the comfort of their own home, using a novel electronic screening device.